Slowly evolving, immune-mediated diabetes in 14-year-old patient: a case report
Slowly developing immune-mediated diabetes, often called latent autoimmune diabetes in adults, is characterized by the presence of autoantibodies (ATs) to glutamic acid decarboxylase (GADA), the patient's age at the onset over 35 years, and the absence of the need for insulin therapy for 6-12 m...
Guardado en:
Autores principales: | M. R. Ragimov, D. D. Omelchuk, L. I. Ibragimova, O. S. Derevyanko, T. V. Nikonova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4da7d16d4cf9412a95303ac183b7e4ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Autoimmune gastritis: comorbid pathology in type 1 diabetes
por: Olga S. Derevyanko, et al.
Publicado: (2018) -
Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives
por: Nishimura A, et al.
Publicado: (2019) -
In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China
por: Yu X, et al.
Publicado: (2021) -
One-hour postload plasma glucose levels as a new criterion for assessing insulin secretion in obese children
por: O. V. Vasyukova, et al.
Publicado: (2021) -
Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2010)